F-actin reactive smooth muscle antibody in subjects with normal liver function

References

• Cowling D C, Mackay I R, Taft L I. Lupoid hepatitis. Lancet 1956; 271: 1323–1326
   PubMed Web of Science ®Google Scholar
• Mackay I R, Weiden S, Hasker J. Autoimmune hepatitis. Ann NY Acad Sci 1965; 124: 767–780
   PubMed Web of Science ®Google Scholar
• Johnson G D, Holborow E J, Glynn L E. Antibody to smooth muscle in patients with liver disease. Lancet 1965; 2: 878–879
   PubMed Web of Science ®Google Scholar
• Toh B H. Smooth muscle autoantibodies and autoantigens. Clin Exp Immunol 1979; 38: 621–628
   PubMed Web of Science ®Google Scholar
• Whittingham S, Mackay I R, Irwin J. Autoimmune hepatitis. Immunofluorescence reactions with cytoplasm of smooth muscle and renal glomerular cells. Lancet 1966; 1: 1333–1335
   PubMed Web of Science ®Google Scholar
• Gabbiani G, Ryan G B, Lamelin J P, et al. Human smooth muscle autoantibody. Its identification as antiactin antibody and a study of its binding to ‘nonmuscular’ cells. Am J Pathol 1973; 72: 473–488
   PubMed Web of Science ®Google Scholar
• Bottazzo G F, Florin-Christensen A, Fairfax A, Swana G, Doniach D, Groeschel-Stewart U. Classification of smooth muscle autoantibodies detected by immunofluorescence. J Clin Pathol 1976; 29: 403–410
   PubMed Web of Science ®Google Scholar
• Silvestrini R A, Benson E M. Whither smooth muscle antibodies in the third millennium?. J Clin Pathol 2001; 54: 677–678, Review
   PubMed Web of Science ®Google Scholar
• Ceredig R, Toh B H. Reaction of human smooth muscle autoantibody with gastric parietal cells: a pitfall in the diagnosis of parietal cell autoantibody. J Clin Pathol 1977; 30: 666–670
   PubMed Web of Science ®Google Scholar
• Toh B H, Gallichio H A, Jeffrey P L, et al. Anti-actin stains synapses. Nature 1976; 264: 648–650
   PubMed Web of Science ®Google Scholar
• Kurki P, Linder E, Virtanen I, Stenman S. Human smooth muscle autoantibodies reacting with intermediate (100 A) filaments. Nature 1977; 268: 240–241
   PubMed Web of Science ®Google Scholar
• Kurki P, Virtanen I. The detection of human antibodies against cytoskeletal components. J Immunol Methods 1984; 67: 209–223, Review
   PubMed Web of Science ®Google Scholar
• Toh B H. Anti-cytoskeletal autoantibodies: diagnostic significance for liver diseases, infections and systemic autoimmune diseases. Autoimmunity 1991; 11: 119–125, Review
   PubMed Web of Science ®Google Scholar
• Granito A, Muratori L, Muratori P, et al. Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. J Clin Pathol 2006; 59: 280–284
   PubMed Web of Science ®Google Scholar
• Frenzel C, Herkel J, Luth S, Galle P R, Schramm C, Lohse A W. Evaluation of F-actin ELISA for the diagnosis of autoimmune hepatitis. Am J Gastroenterol 2006; 101: 2731–2736
   PubMed Web of Science ®Google Scholar
• Liaskos C, Bogdanos D P, Davies E T, Dalekos G N. Diagnostic relevance of anti-filamentous actin antibodies in autoimmune hepatitis. J Clin Pathol 2007; 60: 107–108
   PubMed Web of Science ®Google Scholar
• Jaskowski T D, Konnick E Q, Ashwood E R, Litwin C M, Hill H R. Prevalence of IgG autoantibody against F-actin in patients suspected of having autoimmune or acute viral hepatitis. J Clin Lab Anal 2007; 21: 249–253
   PubMed Web of Science ®Google Scholar
• Pollock W, Toh B H. Routine immunofluorescence detection of Ro/SS-A autoantibody using HEp-2 cells transfected with human 60 kDa Ro/SS-A. J Clin Pathol 1999; 52: 684–687
   PubMed Web of Science ®Google Scholar
• Pedersen J S, Toh B H, Mackay I R, Tait B D, Gust I D, Kastelan A, et al. Segregation of autoantibody to cytoskeletal filaments, actin and intermediate filaments with two types of chronic active hepatitis. Clin Exp Immunol 1982; 48: 527–532
   PubMed Web of Science ®Google Scholar
• Brown C, Pedersen J, Underwood J R, Gust I, Toh B H. Autoantibodies to intermediate filaments in acute viral hepatitis A, B and non-A, non-B are directed against vimentin. J Clin Lab Immunol 1986; 19: 1–4
   PubMedGoogle Scholar
• Dighiero G, Lymberi P, Monot C, Abuaf N. Sera with high levels of anti-smooth muscle and anti-mitochondrial antibodies frequently bind to cytoskeleton proteins. Clin Exp Immunol 1990; 82: 52–56
   PubMed Web of Science ®Google Scholar
• Bretherton L, Brown C, Pedersen J S, et al. ELISA assay for IgG autoantibody to G-actin: comparison of chronic active hepatitis and acute viral hepatitis. Clin Exp Immunol 1983; 51: 611–616
   PubMed Web of Science ®Google Scholar
• Cunningham A L, Mackay I R, Frazer I H, et al. Antibody to G-actin in different categories of alcoholic liver disease: quantification by an ELISA and significance for alcoholic cirrhosis. Clin Immunol Immunopathol 1985; 34: 158–164
   PubMedGoogle Scholar
• Fabbro E, Rubert L, Quaglia S, et al. Uselessness of anti-actin antibody in celiac disease screening. Clin Chim Acta 2008; 390(1–2)134–137
   PubMed Web of Science ®Google Scholar
• Prince M I, Chetwynd A, Craig W L, Metcalf J V, James O F. Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort. Gut 2004; 53: 865–870
   PubMed Web of Science ®Google Scholar
• Toh B H, van Driel I R, Gleeson P A. Pernicious anemia. N Engl J Med 1997; 337: 1441–1448, Review
   PubMed Web of Science ®Google Scholar
• Rantapaa-Dahlqvist S, de Jong B A, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48: 2741–2749
   PubMed Web of Science ®Google Scholar
• Arbuckle M R, McClain M T, Rubertone M V, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526–1533
   PubMed Web of Science ®Google Scholar